Impact of Ruxolitinib in Myelofibrosis Allogeneic Stem Cell Transplant Outcome---a Pilot Study

被引：0
|
作者：
Poulose, Joyson
Malysz, Jozef
Claxton, David F.
Ehmann, W. Christopher
Mineishi, Shin
Rybka, Witold B.
Hohl, Raymond J.
Pu, Jeffrey J.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5543
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of ruxolitinib in myelofibrosis post allogeneic stem cell transplant: A pilot study.
    Poulose, Joyson
    Pu, Jeffrey J.
    Malysz, Jozef
    Bayerl, Michael
    Fanburg-Smith, Julie
    Hohl, Raymond J.
    Mineishi, Shin
    Zhu, Junjia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Impact of ruxolitinib on myelofibrosis patients post allogeneic stem cell transplant-a pilot study
    Pu, Jeffrey J.
    Poulose, Joyson
    Malysz, Jozef
    Zhu, Junjia
    Fanburg-Smith, Julie C.
    Claxton, David F.
    Bayerl, Michael G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (05) : E130 - E133
  • [3] Impact of Pre-Transplant Ruxolitinib in Myelofibrosis Patients on Outcome after Allogeneic Stem Cell Transplantation
    Abd Kadir, Sharifah Shahnaz Syed
    Zabelina, Tatjana
    Christopeit, Maximilian
    Wulf, Gerald G.
    Wagner, Eva Maria
    Bornhaeuser, Martin
    Schroeder, Thomas
    Crysandt, Martina
    Mayer, Karin
    Stelljes, Matthias
    Badbaran, Anita
    Wolschke, Christine
    Ayuk, Francis A.
    Triviai, Ioanna N.
    Wolf, Dominik
    Kroeger, Nicolaus
    BLOOD, 2016, 128 (22)
  • [4] Impact of pre-transplant ruxolitinib in myelofibrosis patients on outcome after allogeneic stem cell transplantation
    Abd Kadir, Syed
    Shahnaz, Sharifah
    Zabelina, Tatjana
    Christopeit, Maximilian
    Wulf, Gerald
    Wagner, Eva
    Bornhaeuser, Martin
    Schroeder, Thomas
    Crysandt, Martina
    Mayer, Karin Tina
    Stelljes, Matthias
    Badbaran, Anita
    Wolschke, Christine
    Ayuketang, Ayuk Francis
    Triviai, Ioanna
    Wolf, Dominik
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2017, 52 : S423 - S423
  • [5] Ruxolitinib Maintenance Post Myelofibrosis Allogeneic Stem Cell Transplant
    Pu, Jeffrey J.
    Poulose, Joyson
    Zhu, Junjia
    Malysz, Jozef
    Fanburg-Smith, Julie
    Bayerl, Michael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [6] Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis
    Abd Kadir, Sharifah Shahnaz Syed
    Christopeit, Maximilian
    Wulf, Gerald
    Wagner, Eva
    Bornhauser, Martin
    Schroeder, Thomas
    Crysandt, Martina
    Mayer, Karin
    Jonas, Julia
    Stelljes, Matthias
    Badbaran, Anita
    Ayuk, Francis Ayuketang
    Triviai, Ioanna
    Wolf, Dominik
    Wolschke, Christine
    Kroeger, Nicolaus
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 305 - 317
  • [7] Ruxolitinib As Pretreatment Before Allogeneic Stem Cell Transplantation For Myelofibrosis
    Kroeger, Nicolaus
    Alchalby, Haefaa
    Ditschkowski, Markus
    Wolf, Dominik
    Wulf, Gerald
    Zabelina, Tatjana
    Wolschke, Christine
    Stuebig, Thomas
    Ayuk, Francis
    BLOOD, 2013, 122 (21)
  • [8] Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
    Sora, Federica
    Giammarco, Sabrina
    Raiola, Anna Maria
    Di Grazia, Carmen
    Bregante, Stefania
    Gualandi, Francesca
    Varaldo, Riccardo
    Chiusolo, Patrizia
    Sica, Simona
    Laurenti, Luca
    Innocenti, Idanna
    Autore, Francesco
    Metafuni, Elisabetta
    Galli, Eugenio
    Bacigalupo, Andrea
    Angelucci, Emanuele
    BLOOD CANCER JOURNAL, 2022, 12 (07)
  • [9] Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
    Federica Sora
    Sabrina Giammarco
    Anna Maria Raiola
    Carmen Di Grazia
    Stefania Bregante
    Francesca Gualandi
    Riccardo Varaldo
    Patrizia Chiusolo
    Simona Sica
    Luca Laurenti
    Idanna Innocenti
    Francesco Autore
    Elisabetta Metafuni
    Eugenio Galli
    Andrea Bacigalupo
    Emanuele Angelucci
    Blood Cancer Journal, 12
  • [10] Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
    Kroeger, Nicolaus
    Sbianchi, Giulia
    Sirait, Tiarlan
    Wolschke, Christine
    Beelen, Dietrich
    Passweg, Jakob
    Robin, Marie
    Vrhovac, Radovan
    Helbig, Grzegorz
    Sockel, Katja
    Conneally, Eibhlin
    Rubio, Marie Therese
    Beguin, Yves
    Finke, Juergen
    Bernasconi, Paolo
    Morozova, Elena
    Clausen, Johannes
    von dem Borne, Peter
    Schaap, Nicolaas
    Schroyens, Wilfried
    Patriarca, Francesca
    Di Renzo, Nicola
    Yegin, Zeynep Arzu
    Hayden, Patrick
    McLornan, Donal
    Yakoub-Agha, Ibrahim
    LEUKEMIA, 2021, 35 (12) : 3551 - 3560
12345